Hereditary angioedema: Validation of the end point time to onset of relief by correlation with symptom intensity.
暂无分享,去创建一个
J. Bernstein | B. Ritchie | T. Craig | R. Wasserman | K. Obtulowicz | A. Reshef | R. Levy | P. Kiessling | A. Bewtra | H. Keinecke | D. Moldovan | D. Hurewitz | V. Grivcheva-Panovska | T. Shirov
[1] B. Zuraw,et al. Update on therapeutic developments for hereditary angioedema. , 2009, Allergy and asthma proceedings.
[2] B. Zuraw,et al. Pathogenesis and laboratory diagnosis of hereditary angioedema. , 2009, Allergy and asthma proceedings.
[3] K. Wyrwich,et al. Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema , 2009, Quality of Life Research.
[4] M. Cicardi,et al. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. , 2009, Trends in molecular medicine.
[5] K. Bork. Pasteurized C1 inhibitor concentrate in hereditary angioedema: pharmacology, safety, efficacy and future directions , 2008, Expert review of clinical immunology.
[6] M. Frank. Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[7] William H. Yang,et al. Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[8] Lynda Schneider,et al. Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitor. , 2007, The Journal of allergy and clinical immunology.
[9] K. Bork,et al. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. , 2006, Biochemical and biophysical research communications.
[10] M. Gompels,et al. C1 inhibitor deficiency: consensus document , 2005, Clinical and experimental immunology.
[11] William H. Yang,et al. Canadian 2003 International Consensus Algorithm For the Diagnosis, Therapy, and Management of Hereditary Angioedema. , 2004, The Journal of allergy and clinical immunology.
[12] F. Rosen,et al. A randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema , 1998, Transfusion.
[13] F. Rosen,et al. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. , 1996, The New England journal of medicine.
[14] M. Cicardi,et al. Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.